vs
亚什兰（ASH）与SSR MINING INC.（SSRM）财务数据对比。点击上方公司名可切换其他公司
SSR MINING INC.的季度营收约是亚什兰的1.4倍（$521.7M vs $386.0M），SSR MINING INC.净利率更高（34.8% vs -3.1%，领先37.9%），SSR MINING INC.同比增速更快（61.4% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $106.4M），过去两年SSR MINING INC.的营收复合增速更高（50.5% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
SSR Mining Inc.（前身为白银标准资源公司）总部位于美国科罗拉多州丹佛，主营金、银、铜、铅、锌矿产开采，拥有阿根廷最大的银矿，同时在美洲全境及土耳其开展矿产勘探业务。2020年与阿拉瑟黄金合并后迁至丹佛，现任总裁兼首席执行官为罗德尼·P·安塔尔。
ASH vs SSRM — 直观对比
营收规模更大
SSRM
是对方的1.4倍
$386.0M
营收增速更快
SSRM
高出66.1%
-4.7%
净利率更高
SSRM
高出37.9%
-3.1%
自由现金流更多
ASH
多$4.6M
$106.4M
两年增速更快
SSRM
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $521.7M |
| 净利润 | $-12.0M | $181.5M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -1.6% | 38.8% |
| 净利率 | -3.1% | 34.8% |
| 营收同比 | -4.7% | 61.4% |
| 净利润同比 | 92.7% | 3166.6% |
| 每股收益（稀释后） | $-0.26 | $0.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHSSRM
| Q4 25 | $386.0M | $521.7M | ||
| Q3 25 | $477.0M | $385.8M | ||
| Q2 25 | $463.0M | $405.5M | ||
| Q1 25 | $479.0M | $316.6M | ||
| Q4 24 | $405.0M | $323.2M | ||
| Q3 24 | $521.0M | $257.4M | ||
| Q2 24 | $544.0M | $184.8M | ||
| Q1 24 | $575.0M | $230.2M |
净利润ASHSSRM
| Q4 25 | $-12.0M | $181.5M | ||
| Q3 25 | $31.0M | $65.4M | ||
| Q2 25 | $-742.0M | $90.1M | ||
| Q1 25 | $31.0M | $58.8M | ||
| Q4 24 | $-165.0M | $5.6M | ||
| Q3 24 | $17.0M | $10.6M | ||
| Q2 24 | $6.0M | $9.7M | ||
| Q1 24 | $120.0M | $-287.1M |
毛利率ASHSSRM
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 33.2% | — | ||
| Q2 24 | 34.2% | — | ||
| Q1 24 | 28.0% | — |
营业利润率ASHSSRM
| Q4 25 | -1.6% | 38.8% | ||
| Q3 25 | 12.8% | 21.6% | ||
| Q2 25 | -152.9% | 26.9% | ||
| Q1 25 | 10.6% | 21.1% | ||
| Q4 24 | -44.2% | 10.6% | ||
| Q3 24 | 6.1% | 3.5% | ||
| Q2 24 | -11.2% | 5.8% | ||
| Q1 24 | 3.7% | -163.5% |
净利率ASHSSRM
| Q4 25 | -3.1% | 34.8% | ||
| Q3 25 | 6.5% | 17.0% | ||
| Q2 25 | -160.3% | 22.2% | ||
| Q1 25 | 6.5% | 18.6% | ||
| Q4 24 | -40.7% | 1.7% | ||
| Q3 24 | 3.3% | 4.1% | ||
| Q2 24 | 1.1% | 5.2% | ||
| Q1 24 | 20.9% | -124.7% |
每股收益（稀释后）ASHSSRM
| Q4 25 | $-0.26 | $0.84 | ||
| Q3 25 | $0.83 | $0.31 | ||
| Q2 25 | $-16.21 | $0.42 | ||
| Q1 25 | $0.65 | $0.28 | ||
| Q4 24 | $-3.50 | $0.03 | ||
| Q3 24 | $0.34 | $0.05 | ||
| Q2 24 | $0.12 | $0.05 | ||
| Q1 24 | $2.39 | $-1.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $575.6M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $3.5B |
| 总资产 | $4.5B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHSSRM
| Q4 25 | $304.0M | $575.6M | ||
| Q3 25 | $215.0M | $445.4M | ||
| Q2 25 | $207.0M | $438.5M | ||
| Q1 25 | $168.0M | $341.3M | ||
| Q4 24 | $219.0M | $417.3M | ||
| Q3 24 | $300.0M | $365.8M | ||
| Q2 24 | $399.0M | $384.4M | ||
| Q1 24 | $439.0M | $492.0M |
总债务ASHSSRM
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $228.6M | ||
| Q3 24 | $1.3B | $228.3M | ||
| Q2 24 | $1.3B | $228.0M | ||
| Q1 24 | $1.3B | $228.7M |
股东权益ASHSSRM
| Q4 25 | $1.9B | $3.5B | ||
| Q3 25 | $1.9B | $3.3B | ||
| Q2 25 | $1.9B | $3.3B | ||
| Q1 25 | $2.6B | $3.2B | ||
| Q4 24 | $2.6B | $3.1B | ||
| Q3 24 | $2.9B | $3.1B | ||
| Q2 24 | $3.0B | $3.1B | ||
| Q1 24 | $3.1B | $3.1B |
总资产ASHSSRM
| Q4 25 | $4.5B | $6.1B | ||
| Q3 25 | $4.6B | $5.9B | ||
| Q2 25 | $4.6B | $5.8B | ||
| Q1 25 | $5.2B | $5.6B | ||
| Q4 24 | $5.2B | $5.2B | ||
| Q3 24 | $5.6B | $5.1B | ||
| Q2 24 | $5.7B | $5.2B | ||
| Q1 24 | $5.9B | $5.3B |
负债/权益比ASHSSRM
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | 0.07× | ||
| Q3 24 | 0.47× | 0.07× | ||
| Q2 24 | 0.45× | 0.07× | ||
| Q1 24 | 0.42× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $172.1M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $106.4M |
| 自由现金流率自由现金流/营收 | 28.8% | 20.4% |
| 资本支出强度资本支出/营收 | 3.6% | 12.6% |
| 现金转化率经营现金流/净利润 | — | 0.95× |
| 过去12个月自由现金流最近4个季度 | $200.0M | $241.6M |
8季度趋势，按日历期对齐
经营现金流ASHSSRM
| Q4 25 | $125.0M | $172.1M | ||
| Q3 25 | $40.0M | $57.2M | ||
| Q2 25 | $115.0M | $157.8M | ||
| Q1 25 | $9.0M | $84.8M | ||
| Q4 24 | $-30.0M | $95.0M | ||
| Q3 24 | $80.0M | $-1.3M | ||
| Q2 24 | $127.0M | $-78.1M | ||
| Q1 24 | $54.0M | $24.6M |
自由现金流ASHSSRM
| Q4 25 | $111.0M | $106.4M | ||
| Q3 25 | $6.0M | $-2.4M | ||
| Q2 25 | $95.0M | $98.4M | ||
| Q1 25 | $-12.0M | $39.3M | ||
| Q4 24 | $-53.0M | $56.4M | ||
| Q3 24 | $42.0M | $-34.1M | ||
| Q2 24 | $98.0M | $-116.3M | ||
| Q1 24 | $20.0M | $-9.4M |
自由现金流率ASHSSRM
| Q4 25 | 28.8% | 20.4% | ||
| Q3 25 | 1.3% | -0.6% | ||
| Q2 25 | 20.5% | 24.3% | ||
| Q1 25 | -2.5% | 12.4% | ||
| Q4 24 | -13.1% | 17.5% | ||
| Q3 24 | 8.1% | -13.2% | ||
| Q2 24 | 18.0% | -62.9% | ||
| Q1 24 | 3.5% | -4.1% |
资本支出强度ASHSSRM
| Q4 25 | 3.6% | 12.6% | ||
| Q3 25 | 7.1% | 15.4% | ||
| Q2 25 | 4.3% | 14.7% | ||
| Q1 25 | 4.4% | 14.4% | ||
| Q4 24 | 5.7% | 11.9% | ||
| Q3 24 | 7.3% | 12.7% | ||
| Q2 24 | 5.3% | 20.7% | ||
| Q1 24 | 5.9% | 14.8% |
现金转化率ASHSSRM
| Q4 25 | — | 0.95× | ||
| Q3 25 | 1.29× | 0.87× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | 0.29× | 1.44× | ||
| Q4 24 | — | 17.10× | ||
| Q3 24 | 4.71× | -0.13× | ||
| Q2 24 | 21.17× | -8.06× | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
SSRM
| Gold | $369.3M | 71% |
| Concentrate Sales | $124.4M | 24% |
| Other | $19.1M | 4% |
| Lead | $9.0M | 2% |
